AML Discovery

Exciting news out of the lab of grantee Dr. Saar Gill at the University of Pennsylvania. A new approach pioneered at the Abramson Cancer Center may provide a new path towards treating Acute Myeloid Leukemia (AML) with CAR T cells. “Think of this as bone marrow transplant 2.0; the next generation of transplants,” Gill said. “It gives you a super powerful anti-leukemia effect thanks to the CAR T cells, but at the same time it has the potential to get rid of the main toxicity.”

The Foundation’s Medical Advisory Board selects 10 top junior investigators to receive our three-year, $225,000 Medical Research Award. The Foundation also announces support for nine one-year grants; the Director’s Innovation Fund at the Sylvester Comprehensive Cancer Center in Miami, FL; one ASBMT New Investigator Award; two music therapy programs; and assorted symposia and medical conferences.